{"id":39186,"date":"2026-06-16T15:36:43","date_gmt":"2026-06-16T13:36:43","guid":{"rendered":"https:\/\/ggba.swiss\/impli-secures-gbp-1-4-million-grant-to-advance-continuous-hormone-monitoring-for-ivf\/"},"modified":"2026-06-16T15:39:08","modified_gmt":"2026-06-16T13:39:08","slug":"impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/","title":{"rendered":"Impli d\u00e9croche une bourse GBP 1,4 million pour le suivi hormonal continu en FIV"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.impli.co\/\">Impli<\/a>, une entreprise deeptech d\u00e9veloppant le suivi mol\u00e9culaire continu pour la sant\u00e9 hormonale, a obtenu une bourse de GBP 1,4 million du programme Invention for Innovation du National Institute for Health and Care Research (<a href=\"https:\/\/www.nihr.ac.uk\/\">NIHR<\/a>) du Royaume-Uni. Ce financement fera progresser BEAM (Bio-Endocrine Analysis Monitor), un patch \u00e0 micro-aiguilles peu invasif, vers la validation clinique pour une utilisation dans la f\u00e9condation in vitro (FIV). Fond\u00e9e comme spin-off d&rsquo;Imperial College London, Impli maintient une pr\u00e9sence sur le campus des sciences de la vie <a href=\"https:\/\/www.biopole.ch\/\">Biop\u00f4le<\/a> \u00e0 Lausanne depuis 2021.<\/p>\n\n\n\n<p>La bourse soutient un programme de consortium de 30 mois r\u00e9unissant Impli, l&rsquo;Imperial College Healthcare NHS Trust, le King&rsquo;s College London et le r\u00e9seau de patients Fertility Europe, aux c\u00f4t\u00e9s du fabricant de dispositifs m\u00e9dicaux TTP. Le programme am\u00e8nera BEAM du prototype \u00e0 la premi\u00e8re validation chez l&rsquo;humain, avec une \u00e9tude pilote sur 25 participantes et la pr\u00e9paration r\u00e9glementaire et m\u00e9dico-\u00e9conomique en vue d&rsquo;une adoption par le National Health Service britannique.<\/p>\n\n\n\n<p>Port\u00e9 sur le haut du bras, le patch BEAM utilise des biocapteurs \u00e9lectrochimiques \u00e0 base d&rsquo;aptam\u00e8res pour mesurer en continu l&rsquo;estradiol, l&rsquo;hormone lut\u00e9inisante et la progest\u00e9rone dans le liquide interstitiel, transmettant les donn\u00e9es \u00e0 un smartphone o\u00f9 des algorithmes d&rsquo;IA convertissent les signaux en tendances hormonales en temps r\u00e9el. L&rsquo;infertilit\u00e9 touche une personne sur six dans le monde, et les cycles de FIV n\u00e9cessitent actuellement jusqu&rsquo;\u00e0 dix visites en clinique pour des prises de sang, les cliniciens agissant souvent sur des valeurs hormonales vieilles d&rsquo;un \u00e0 deux jours. En r\u00e9duisant ces visites \u00e0 deux au minimum, le patch vise \u00e0 permettre des ajustements th\u00e9rapeutiques personnalis\u00e9s en temps r\u00e9el.<\/p>\n\n\n\n<p>L&#8217;empreinte suisse d&rsquo;Impli ne se limite pas \u00e0 sa base lausannoise : l&rsquo;entreprise a d\u00e9velopp\u00e9 son biocapteur implantable CERES en collaboration avec le <a href=\"https:\/\/www.csem.ch\/fr\/\">CSEM<\/a> et la start-up zougoise Yalosys, dans le cadre d&rsquo;un projet soutenu par Innosuisse. Si sa premi\u00e8re indication est la FIV, BEAM est con\u00e7u comme une plateforme aux applications potentielles dans diverses affections hormonales, du syndrome des ovaires polykystiques \u00e0 l&rsquo;endom\u00e9triose en passant par la m\u00e9nopause.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Impli, l&rsquo;entreprise deeptech d\u00e9veloppant le suivi mol\u00e9culaire continu pour la sant\u00e9 hormonale et pr\u00e9sente au Biop\u00f4le de Lausanne, a obtenu une bourse de 1,4 million de livres pour amener son patch de suivi hormonal vers la validation clinique dans la f\u00e9condation in vitro.<\/p>\n","protected":false},"author":6,"featured_media":39183,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1179,1180,1148,1188,1181],"class_list":["post-39186","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Impli d\u00e9croche une bourse pour son patch hormonal | GGBa<\/title>\n<meta name=\"description\" content=\"Impli a d\u00e9croch\u00e9 une bourse de 1,4 million de livres pour faire progresser son patch de suivi hormonal continu d\u00e9di\u00e9 \u00e0 la FIV.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impli d\u00e9croche une bourse pour son patch hormonal | GGBa\" \/>\n<meta property=\"og:description\" content=\"Impli a d\u00e9croch\u00e9 une bourse de 1,4 million de livres pour faire progresser son patch de suivi hormonal continu d\u00e9di\u00e9 \u00e0 la FIV.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-16T13:36:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T13:39:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1273\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Impli d\u00e9croche une bourse GBP 1,4 million pour le suivi hormonal continu en FIV\",\"datePublished\":\"2026-06-16T13:36:43+00:00\",\"dateModified\":\"2026-06-16T13:39:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\"},\"wordCount\":382,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Financing\",\"Healthcare\",\"Medical Devices\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\",\"name\":\"Impli d\u00e9croche une bourse pour son patch hormonal | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png\",\"datePublished\":\"2026-06-16T13:36:43+00:00\",\"dateModified\":\"2026-06-16T13:39:08+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Impli a d\u00e9croch\u00e9 une bourse de 1,4 million de livres pour faire progresser son patch de suivi hormonal continu d\u00e9di\u00e9 \u00e0 la FIV.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png\",\"width\":1273,\"height\":811,\"caption\":\"Le patch BEAM d'Impli utilise des biocapteurs \u00e0 micro-aiguilles pour suivre les hormones en continu dans le cadre d'un traitement de FIV. L'entreprise femtech maintient une pr\u00e9sence au Biop\u00f4le de Lausanne. | \u00a9 Impli\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impli d\u00e9croche une bourse GBP 1,4 million pour le suivi hormonal continu en FIV\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Impli d\u00e9croche une bourse pour son patch hormonal | GGBa","description":"Impli a d\u00e9croch\u00e9 une bourse de 1,4 million de livres pour faire progresser son patch de suivi hormonal continu d\u00e9di\u00e9 \u00e0 la FIV.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/","og_locale":"fr_FR","og_type":"article","og_title":"Impli d\u00e9croche une bourse pour son patch hormonal | GGBa","og_description":"Impli a d\u00e9croch\u00e9 une bourse de 1,4 million de livres pour faire progresser son patch de suivi hormonal continu d\u00e9di\u00e9 \u00e0 la FIV.","og_url":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-06-16T13:36:43+00:00","article_modified_time":"2026-06-16T13:39:08+00:00","og_image":[{"width":1273,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Impli d\u00e9croche une bourse GBP 1,4 million pour le suivi hormonal continu en FIV","datePublished":"2026-06-16T13:36:43+00:00","dateModified":"2026-06-16T13:39:08+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/"},"wordCount":382,"image":{"@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png","keywords":["Artificial Intelligence","Digital Health","Financing","Healthcare","Medical Devices"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/","url":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/","name":"Impli d\u00e9croche une bourse pour son patch hormonal | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png","datePublished":"2026-06-16T13:36:43+00:00","dateModified":"2026-06-16T13:39:08+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Impli a d\u00e9croch\u00e9 une bourse de 1,4 million de livres pour faire progresser son patch de suivi hormonal continu d\u00e9di\u00e9 \u00e0 la FIV.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/06\/Impli-Beam-Patch-1180x811-1.png","width":1273,"height":811,"caption":"Le patch BEAM d'Impli utilise des biocapteurs \u00e0 micro-aiguilles pour suivre les hormones en continu dans le cadre d'un traitement de FIV. L'entreprise femtech maintient une pr\u00e9sence au Biop\u00f4le de Lausanne. | \u00a9 Impli"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/impli-decroche-une-bourse-gbp-14-million-pour-le-suivi-hormonal-continu-en-fiv\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Impli d\u00e9croche une bourse GBP 1,4 million pour le suivi hormonal continu en FIV"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=39186"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39186\/revisions"}],"predecessor-version":[{"id":39188,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39186\/revisions\/39188"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/39183"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=39186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=39186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=39186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}